Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

For patients with lung cancer, biomarker testing may be an option.

The majority of Europeans can’t identify the warning signs of heart failure, a life threatening disease, which affects one in five people in the region.

The culture of volunteerism is a fundamental part of the Novartis corporate ethos. Here’s a snapshot of our efforts over the years.

A conversation with Joachim Momm, head of a Novartis manufacturing site that will be helping to produce Pfizer-BioNTech vaccine doses.

Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success

Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Targeting inflammation to fight cancer is a new approach with a long history.

Novartis researchers aim to improve the lives of patients with osteoarthritis.